Breaking News on Pharmaceutical Technology

Headlines > Processing & QC

MFIC reports revenues boosted by microfluidics

07-Feb-2007 - US-based nanotech process provider MFIC has announced a 35 per cent increase in revenue over the full-year 2006 to $15.7m (€12.1m), driven by a rising demand from drugmakers for microfluidics products.

Cardinal Health placates FDA with Alaris pump action

07-Feb-2007 - Cardinal Health has reached an agreement with the US Food and Drug Administration (FDA) on plans to resume manufacture and sale of its Alaris (SE) line of infusion pumps. Units were seized and production halted following grave safety concerns surrounding the product back in 2006.

Laureate and Boehringer in bioprocessing partnership

07-Feb-2007 - Laureate Pharma will now offer extra bioprocessing services to its customers following a new partnership deal signed with Boehringer Ingelheim.

MDS Pharma closes Quebec facility following FDA probe

06-Feb-2007 - MDS pharma has ceased operations at its bioanalytical services facility in Blainville, Quebec in a bid to boost profitability after an ongoing investigation of the site by the US Food and Drug Administration (FDA).

Tolmar in sale-leaseback deal to snap up QLT USA

06-Feb-2007 - Private pharmaceutical firm Tolmar has sold off its pharmaceutical manufacturing plant in a move to fund the purchase of the US assets of biopharmaceutical QLT. The plant, sold for $13.6m (€10.5m), will be leased back to Tolmar under a long-term triple net lease.

Millipore reports Q4 income surge

05-Feb-2007 - US-based biopharmaceutical product providers Millipore has met its revenue and earnings target over the fiscal year, helped by its Serologicals acquisition in the fourth quarter and a solid performance by its main business driver: lab waters.

UK organisation issues hazardous waste advice

05-Feb-2007 - A UK-based firm is offering advice to chemical and pharmaceutical companies on reducing hazardous waste and adhering to the Registration, Evaluation and Authorisation of Chemicals Regulation (REACH), which becomes law on 1 June 2007.

Roche Diagnostics and 454 launch next generation sequencer

02-Feb-2007 - The first next generation sequencer from Roche and 454 is already proving popular only weeks after its release.

Multiplexed microfluidic separations

02-Feb-2007 - A new 'lab-on-a-chip' electrophoresis separation device allows higher resolution separations and could enable faster diabetes immunoassay diagnoses.

Disposables prove lucrative for Sartorius

01-Feb-2007 - Sartorius has reported 7.6 per cent increase in sales revenue in 2006 rising to €520.1m ($677.4m), due to the biotechnology division's decision to focus on disposable systems.

Steris posts mixed 3Q results

01-Feb-2007 - US-based sterilisation system providers Steris this week announced their fiscal 2007 third quarter results, revealing the impact of the relocation of manufacturing capacity to Mexico and the firm's European restructuring.

Contract manufacturing news in brief

31-Jan-2007 - Hospira, Laureate Pharma, QSV Biologics and Cook Pharmacia all bagged new contract manufacturing deals this week.

Pharsight says software makes bioequivalence testing easy

31-Jan-2007 - Software provider Pharsight has launched an add-on for its graphical drug modelling method to serve in bioequivalence testing, promising to reduce test failure.

Lentigen enters disposables market to cut production time

30-Jan-2007 - Viral vector manufacturer Lentigen has entered into a collaboration with Wave Biotech to gain access to disposable process and equipment expertise, which ties in with a shift in the bioprocess manufacturing sector towards using disposable systems.

Xcellerex receives $20m boost for disposable manufacturing tech

30-Jan-2007 - US-based firm Xcellerex yesterday announced it has completed the second half of a $20m (€15.4m) financing deal, raising $11m to speed up commercialisation of its innovative disposable manufacturing technology for vaccines and biotherapeutics.

Spectroscopy sees through packaging to thwart drug fakers

29-Jan-2007 - UK based researchers have added another dimension to anti-counterfeiting with an alternative Raman imaging method that is powerful enough to detect fake drugs without opening the package.

PerkinElmer increases R&D spending

26-Jan-2007 - Increased research and development (R&D) spending masks strong revenue growth by PerkinElmer's life and analytical sciences division.

Pharma sales fuel Waters resurgence

26-Jan-2007 - Waters posted an 11 per cent yearly sales increase on the back of increasing demand from the pharmaceutical industry, generic houses and outsourcing laboratories.

Disappointing year for Whatman

24-Jan-2007 - In a turbulent year, Whatman has failed to meet its projected revenue target by 1-3 per cent and changed its management but resolved litigation that has been hanging over the firm since 2003.

Workhorse analytical tools to reduce human errors

22-Jan-2007 - Agilent Technologies has signed an agreement with Groton Biosystems to co-market measuring solutions for the pharmaceutical industry, as the Process Analytical Technology (PAT) initiative gains popularity among drug manufacturers constantly looking for ways to improve processing efficiencies and costs.

'Global centre of microarray excellence'

19-Jan-2007 - Oxford Gene Technology and Agilent are to collaborate to develop a global centre of microarray excellence focused on new and emerging applications.

Competitors fill void left by CodeLink exit

19-Jan-2007 - Agilent, Illumina, NimbleGen and Oxford Gene Technology have stepped into the breach caused by GE Healthcare's decision to scrap its CodeLink arrays.

Multi-tasking software "harmonises" regulatory affairs

18-Jan-2007 - US-based Blue Mountain has launched an integrated, comprehensive software package to help life sciences companies manage their assets, cutting out the need for individual software.

Celsis hopes for new business from FDA recognition

17-Jan-2007 - The US Food and Drug Administration has accepted two Celsis drug master files (DMFs) that could increase the adoption of its rapid microbiological detection technology among pharmaceutical manufacturers.

Novel extraction method promises ecological low-cost cardiac digoxin production

16-Jan-2007 - Russian researchers have developed a new way of sourcing a widely used cardiovascular drug using an ecologically friendly and water-based extraction method, which could yield three-fold cost savings over conventional approaches.

Sign up for your free newsletter

Supplier Webinars